Concepedia

David Paladino

DP

Statistics

Publications

7

Citations

813

H-Index

7

Active since

2011

Affiliations

Cancer Center of Hawaii(Current)

University of Hawaiʻi at Mānoa

University of Central Florida

University of Hawaii Cancer Center

University of Hawaii System

David Paladino is an author at Cancer Center of Hawaii specializing in signal transduction, oncology, and molecular oncology.

Publications per year

2011–2015

7

Publications

7

Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts

Xiaolei Zhang, Peibin Yue, Brent D. G. Page et al. · Proceedings of the National Academy of Sciences · 2012 · 349 citations · Full text

, , +10

A Functional Nuclear Epidermal Growth Factor Receptor, Src and Stat3 Heteromeric Complex in Pancreatic Cancer Cells

Soumya Jaganathan, Peibin Yue, David Paladino et al. · PLoS ONE · 2011 · 162 citations · Full text

, , +17

Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells

P Yue, Xiaolei Zhang, David Paladino et al. · Oncogene · 2011 · 137 citations · Full text

, , +16

Hydroxamic Acid and Benzoic Acid–Based STAT3 Inhibitors Suppress Human Glioma and Breast Cancer Phenotypes <i>In Vitro</i> and <i>In Vivo</i>

Peibin Yue, Francisco Lopez‐Tapia, David Paladino et al. · Cancer Research · 2015 · 73 citations · Full text

, , +13

A novel nuclear Src and p300 signaling axis controls migratory and invasive behavior in pancreatic cancer

David Paladino, Peibin Yue, Hideki Furuya et al. · Oncotarget · 2015 · 38 citations · Full text

, , +13

1–5 of 7